Emily Tucker, Mark Daskin
The Latest
-
Medical supply chains are fragile in the best of times and COVID-19 will test their strength
The COVID-19 pandemic has brought medical supply chains into the spotlight. There has been a national shortage of testing kits, and at least one drug is already unavailable because of the outbreak, though it hasn’t been publicly named. 
The COVID-19 pandemic has brought medical supply chains into the spotlight. There has been a national shortage of testing kits, and at least one drug is already unavailable because of the outbreak, though it hasn’t been publicly named.
